CONMED CORPORATION Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CONMED CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $0.00.
- CONMED CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $0.00.
- CONMED CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2024 was $0.00.
- CONMED CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-11-06 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |